Effect of dexamethasone on immune response of mice with different behavioral types

Bulletin of Experimental Biology and Medicine

Volumn 139, Issue 5, 2005, Pages 590-592

  Cheido, Margo A ^a   Idova, G V ^a  

^a INSTITUTE OF PHYSIOLOGY   (Russian Federation)

Author keywords

Aggression; Dexamethasone; Immunity; Submission

Indexed keywords

CORTICOTROPIN; DEXAMETHASONE; HALOPERIDOL; IMMUNOGLOBULIN M ANTIBODY; SEROTONIN;

AGGRESSION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOPAMINE RECEPTOR BLOCKING; DOPAMINERGIC SYSTEM; DRUG BLOOD LEVEL; DRUG INHIBITION; DRUG MECHANISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; MALE; MOUSE; NONHUMAN; ROSETTE FORMING CELL; SEROTONINERGIC SYSTEM;

ADRENOCORTICOTROPIC HORMONE; AGGRESSION; ANIMALS; ANTI-INFLAMMATORY AGENTS; BEHAVIOR, ANIMAL; DEXAMETHASONE; IMMUNE SYSTEM; MALE; MICE; MICE, INBRED C57BL;

ANIMALIA;

EID: 24344487940     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-005-0352-9     Document Type: Article

References (14)

1. L. V. Devoino, E. L. Al'perina, N. N. Kudryavtseva, and N. K. Popova, Fiziol. Zh. SSSR, 77, No.12, 62-67 (1991).
2. L. V. Devoino, E. L. Al'perina, E. K. Podgornaya, et al., Byull. Eksp. Biol. Med., 130, No.10, 399-401 (2000).
3. L. V. Devoino and R. Yu. Il'yuchenok, Neurotransmitter Systems in Psychoneuroimmunomodulation: Dopamine, Serotonin, GABA, Neuropeptides [in Russian], Novosibirsk (1993).
4. G. V. Idova, M. A. Cheido, and L. V. Devoino, Zh. Mikrobiol., Epidemiol. Immunobiol., No. 2, 57-60 (1976).
5. N. N. Kudryavtseva and I. V. Bakshtanovskaya, Zh. Vyssh. Nervn. Deyat., 40, No.3, 459-466 (1991).
6. E. V. Naumenko and N. K. Popova, Serotonin and Melatonin in Regulation of the Endocrine System [in Russian], Novosibirsk (1975).
7. A. R. Ase, T. A. Reader, R. Hen, et al., J. Neurochem., 75, No.6, 2415-2426 (2000). 10.1046/j.1471-4159.2000.0752415.x
8. D. C. Blanchard, R. R. Sakai, B. McEwen, et al., Behav. Brain Res., 58, Nos.1-2, 113-121 (1993). 10.1016/0166-4328(93)90096-9
9. D. J. Critchley, K. J. Childs, V. C. Middlefell, and C. T. Dourish, Eur. J. Pharmac., 264, No.1, 95-97 (1994). 10.1016/0014-2999(94)90642-4
10. P. A. Deuster, J. S. Petrides, A. Singh, et al., J. Clin. Endocrinol. Metab., 85, No.3, 1066-1073 (2000). 10.1210/jc.85.3.1066
11. L. V. Devoino, E. L. Al'perina, E. K. Podgornaya, et al., Neurosci. Behav. Physiol., 33, No.5, 473-477 (2003). 10.1023/A:1023463201122
12. D. Franchimont, E. Louis, W. Dewe, et al., Regul. Pept., 73, No.1, 59-65 (1998). 10.1016/S0167-0115(97)01063-X
13. J. Haller, D. T. Kiem, and G. Makara, Behav. Neurosci., 110, No.2, 353-359 (1996). 10.1037//0735-7044.110.2.353
14. K. J. Kovacs and E. Mezey, Neuroendocrinology, 46, No.4, 365-368 (1987). 3499580